November 7, 2018 08:11 AM EST
Bioregnum
Opinion

Bound to the hip with Trump, ex-Cel­gene chief Bob Hug­in gets whipped in New Jer­sey Sen­ate race

This wasn’t Bob Hug­in’s year to start a new ca­reer in pol­i­tics.

The ex-Cel­gene ex­ec, wide­ly laud­ed in the in­vest­ment com­mu­ni­ty for the com­pa­ny’s fast …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times